Apellis Pharmaceuticals (1JK.STU) Q2 2026 Earnings

7MayConfirmed
Q1 2026
Next
-0.4
-0.35
-0.29
-0.24

Details

Expected EPS
-0.23746518432000002
Actual EPS
N/A
Surprise EPS
0.24
Surprise Percent
+100%

Description

Apellis Pharmaceuticals (1JK.STU) will report earnings of for Q2 2026 on May 07, 2026.

0 Comments

Share your thoughts